What question did this study set out to answer?

To evaluate cost benefits of early discharge programs for patients with newly diagnosed acute myeloid leukemia after intensive chemotherapy.

December 8, 2025BloodOpen Access

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals reduced costs with early discharge after intensive chemotherapy in AML patients, suggesting efficient hospital resource use.

To evaluate cost benefits of early discharge programs for patients with newly diagnosed acute myeloid leukemia after intensive chemotherapy.
Analyzed costs from inpatient and outpatient care for newly diagnosed acute myeloid leukemia patients from 2016-2024.
Grouped patients based on absolute neutrophil count (ANC) at discharge: early, intermediate, and traditional.
Utilized statistical analyses like Chi-square and Wilcoxon/Kruskal-Wallis tests to compare outcomes.
Median direct-to-hospital cost was $19,473 for early discharge compared to $23,095 for intermediate and $22,267 for traditional cohorts.
Early discharged patients had significantly fewer days in the hospital and required fewer transfusion clinic visits.
Cost savings per median patient discharged early was $2,779 compared to other cohorts.

Chetlapalli et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Analysis reveals reduced costs with early discharge after intensive chemotherapy in AML patients, suggesting efficient hospital resource use.

To evaluate cost benefits of early discharge programs for patients with newly diagnosed acute myeloid leukemia after intensive chemotherapy.
Analyzed costs from inpatient and outpatient care for newly diagnosed acute myeloid leukemia patients from 2016-2024.
Grouped patients based on absolute neutrophil count (ANC) at discharge: early, intermediate, and traditional.
Utilized statistical analyses like Chi-square and Wilcoxon/Kruskal-Wallis tests to compare outcomes.
Median direct-to-hospital cost was $19,473 for early discharge compared to $23,095 for intermediate and $22,267 for traditional cohorts.
Early discharged patients had significantly fewer days in the hospital and required fewer transfusion clinic visits.
Cost savings per median patient discharged early was $2,779 compared to other cohorts.

Chetlapalli et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark